23rd ECNP Congress: August 28-September 1, 2010, Amsterdam, The Netherlands
The 23rd Congress of the European College of Neuropsychopharmacology (ECNP) will be held from 28 August to 1 September 2010 in Amsterdam, the Netherlands. With more than 150 speakers from 20 countries and 7,000 participants anticipated from all over the world, the ECNP Congress is the largest annual scientific congress on neuropsychopharmacology and mental disorders in Europe.
In more than 35 sessions experts will give insights into the latest achievements and breakthroughs in brain research and neuropsychopharmacology in both preclinical and clinical settings, and discuss the various aspects of pharmacotherapy for patients with mental disorders and their impact on quality of life.
The scientific programme will cover a broad range of topics of major public health interest including, among others:
- The neural basis of the depressive self
- Gene-environment interactions in psychosis
- Circadian rhythms: their role and dysfunction in affective disorder
- Predictors of relapse in alcohol dependence
- Avenues to novel antipsychotics: moving to exploratory strategies
- New potential psychotropic drugs from basic cell neurobiology
- Alpha7 nicotinic receptors: novel therapeutic targets for treating cognitive and attentional deficits
- Neuroprotective therapies: common potential targets in multiple sclerosis, stroke and neurodegenerative disease
Educational update sessions will deal with the neurobiology and treatment of compulsivity in addictive behaviour, the interaction of psychotropic drugs with pain mechanisms, and the integration of pain treatment in psychiatric patient care.
Provided by European College of Neuropsychopharmacology
